RDYDr. Reddy's Laboratories Limited
Oct 19, 2026 — Q2 2026 Earnings Release
Chart by TradingViewThe schedule
- Mon19Oct
Market reaction to the Q2 2026 print amidst a severe YoY net income contraction and elevated technical indicators.
- Fri23Oct
Assessment of US market generic pricing stability and margin defense strategies.
- Fri15Jan
Potential volatility stemming from Trump administration policies regarding imported generic drugs and supply chain tariffs.
- Thu18Feb
Focus on margin resilience and the digestion of supply chain logistics costs.
- Mon10May
Check-in on biosimilar pipeline commercialization and US market share gains.
Past
- Wed30Sep
Expected regulatory clearance or Form 483 observations from US FDA inspections of critical Indian manufacturing sites.
